April 2026 Price Concessions Final Update
The Department of Health and Social Care (DHSC) has today (05/05/2026) confirmed the following final list of price concessions for April 2026:
| Drug | Pack size | Price concession |
| Candesartan 32mg tablets | 28 | £1.57 |
| Candesartan 4mg tablets | 7 | £0.75 |
| Dapagliflozin 10mg tablets | 28 | £6.30 |
| Labetalol 200mg tablets | 56 | £17.87 |
| Lacidipine 4mg tablets | 28 | £1.95 |
| Phenobarbital 15mg tablets | 28 | £5.52 |
| Phenobarbital 60mg tablets | 28 | £3.11 |
| Ramipril 2.5mg capsules | 28 | £0.94 |
| Ramipril 5mg capsules | 28 | £0.82 |
| Sumatriptan 100mg tablets | 6 | £1.10 |
| Tadalafil 5mg tablets | 28 | £2.45 |
| Warfarin 1mg tablets | 28 | £2.20 |
For the full list of price concessions granted for April 2026 please visit our price concession hub page here.
These prices will apply to prescriptions submitted for payment for the dispensing month of April 2026.
Please note: These prices do not apply to May 2026 prescriptions. The first update for this month will be published as soon as we receive a response from the Department.
Notes
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
Top-up payments will be made for certain products if data from the Margin Survey identifies that the original concession prices granted by DHSC were inappropriately low compared to the average pharmacy purchase price for the month. In such cases, a top-up will be triggered automatically and paid on a quarterly basis. More information on retrospective top-ups can be found here.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions)
